PRL and hyperprolactinemia: Hyperprolactinemia favours the intraocular incorporation of PRL and its proteolytic conversion to vasoinhibin [19, 20] which, in turn, can lead to a reduction in VEGF-induced increase in retinal vasopermeability [12–14, 20] (Fig. 3C).